IGLC2 / Immunoglobulin lambda chain antibody
Product Includes
Application Dilution
Immunofluorescence 1:100 – 1:200
Storage
100mM Tris Glycine, 20% Glycerol (pH7). 0.025% ProClin 300 was added as a preservative
Specificity / Sensitivity
Source / Immunogen
Predicted to enable antigen binding activity and immunoglobulin receptor binding activity. Predicted to be involved in several processes, including activation of immune response; defense response to other organism; and phagocytosis. Located in blood microparticle and extracellular exosome. [provided by Alliance of Genome Resources, Apr 2022]
IRCP220601 anti-IGLC2 antibody WB image
Anti-IGLC2 antibody at 1/1000 dilution
Lysates at 30 μg per lane. This blot was produced using a 12% SDS-PAGE. Nitrocellulose membrane was then blocked an hour before being incubated with IRCP220601 overnight at 4°C.
IRCP220601 anti-IGLC2 antibody IHC image
Immunohistochemical analysis of paraffin embedded Human cancer tissue labeling IGLC2 with IRCP220601 at 1/100.
IRCP220601 anti-IGLC2 antibody IHC image
Immunohistochemical analysis of paraffin embedded Human cancer tissue labeling IGLC2 with IRCP220601 at 1/100.
IRCP220601 anti-IGLC2 antibody IHC image
Immunohistochemical analysis of paraffin embedded Human breast cancer tissue labeling IGLC2 with IRCP220601 at 1/100.
IRCP220601 anti-IGLC2 antibody IHC image
Immunohistochemical analysis of paraffin embedded Human breast cancer tissue labeling IGLC2 with IRCP220601 at 1/100.